End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.74 CNY | +1.02% | +0.18% | -9.15% |
Apr. 18 | China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy | MT |
Apr. 17 | Fosun Pharma Unit’s New Drug Application for CMV, HSV Drug Accepted by Chinese Regulator | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.15% | 7.49B | |
+25.46% | 659B | |
+25.45% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.89% | 215B | |
+7.66% | 210B | |
-6.63% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Shanghai Fosun Pharmaceutical : Fosun Pharma to Buy Nearly 59% Stake in Diagnostic Materials Manufacturer for $28 Million